Australia-wide trial launches into take-home naloxone
The Federal Government wants to make the drug more available via doctors and drug treatment centres
AAP
27th February 2019
Take-home naloxone to reverse opioid overdoses will be made available to more Australians through a two-year trial in a bid to curb the increase in deaths.
The drug will be offered at more places frequented by people at risk of overdosing under the pilot program, which will be funded by the Federal Government to the tune of $7.2 million.